This announcement is a separate document:
Abalance：コーポレート・ガバナンスに関する報告書 2024/10/03
Abalance: Corporate Governance Report 2024/10/03
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
19:53
Pfizer's Pre-Market Trading rose by over 3%, and Pfizer expects revenue of 61 billion to 64 billion dollars in 2025, with adjusted EPS of 2.80 to 3.00 dollars in 2025.
PFE-1.29%
19:51
Chongqing Changan Automobile: The holding subsidiary Chongqing Changan Kaicheng plans to increase capital and shareholding through public listing.
Chongqing Changan Automobile+0.14%
19:47
European Central Bank President: The weakening relationship between banks and sovereign debt should provide some comfort.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.